spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Omeros Corp 

 HSMN NewsFeed - 2 Apr 2019
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Mar 2017
OncoResponse Announces Final Closing of $22.5M Series A Financing Round
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 3 Aug 2015
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 22 May 2015
Omidria(R) Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 30 Oct 2014
Omidria(TM) Granted Pass-Through Reimbursement Status from CMS
Biopharmaceuticals Ophthalmology Reimbursement
 HSMN NewsFeed - 2 Jun 2014
Omeros Receives FDA Approval of Omidria(TM) for Use in Cataract and Other Intraocular Lens Replacement Procedures
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 Oct 2013
Omeros Hires Michael K. Inouye to Lead Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2013
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Nov 2012
Omeros Appoints Thomas A. Mitro as Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2012
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
Biopharmaceuticals Neurology Surgery Personnel
 HSMN NewsFeed - 1 Feb 2011
Omeros Announces Eligibility of OMS103HP for EMA Centralized Marketing Application
Biopharmaceuticals Orthopaedic Regulatory
 HSMN NewsFeed - 17 Nov 2010
Omeros Names Dr. Kenneth Ferguson as Vice President, Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Feb 2010
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 5 Aug 2009
Omeros Appoints New Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2008
Omeros Appoints David A. Mann to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2006
Paul Strauss, M.D. Joins Omeros as VP, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2006
Omeros Acquires Nura
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Aug 2006
Omeros Names Greg Perkins, Ph.D., as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
Omeros Corp
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.